Get started
Author

T Shimoyama

Observed names: T SHIMOYAMA, T. Shimoyama, Takahiro SHIMOYAMA, Takahiro Shimoyama
ORCID: 0009-0006-6101-0087
Observed ORCID: 0009-0006-6101-0087
OpenAlex ID: A5083710628
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis
2017 · Makoto Naganuma, Shinya Sugimoto, et al. · Gastroenterology · 209
PDF
Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study
2015 · Takayuki Yamamoto, Antonino Spinelli, et al. · United European Gastroenterology Journal · 84
PDF
Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis
2015 · Takayuki Yamamoto, Takahiro Shimoyama, et al. · The American Journal of Gastroenterology · 67
Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease
2022 · Takahiro Shimoyama, Takayuki Yamamoto, et al. · Inflammatory Bowel Diseases · 54
Tacrolimus vs. anti‐tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study
2016 · T. Yamamoto, T. Shimoyama, et al. · Alimentary Pharmacology & Therapeutics · 52
PDF
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
2023 · Takayuki Yamamoto, Hiroshi Nakase, et al. · Journal of Crohn s and Colitis · 48
PDF
Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis
2015 · T. Yamamoto, T. Shimoyama, et al. · Alimentary Pharmacology & Therapeutics · 48
Diagnosis and Treatment of Essential Fatty Acid Deficiency in Man
1974 · M. Press, H. Kikuchi, et al. · BMJ · 48
PDF
Does preoperative enteral nutrition reduce the incidence of surgical complications in patients with Crohn’s disease? A case‐matched study
2019 · T. Yamamoto, M. Nakahigashi, et al. · Colorectal Disease · 47
Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
2018 · Takayuki Yamamoto, Takahiro Shimoyama, et al. · Clinical and Translational Gastroenterology · 45
Long-term follow-up study of ulcerative colitis in Japan.
1995 · N Hiwatashi, T Yao, et al. · PubMed · 44
Dietary and enteral interventions for Crohn's disease
2016 · Takayuki Yamamoto, Takahiro Shimoyama, et al. · Current Opinion in Biotechnology · 41
Fatty acid composition of plasma lipoproteins in control subjects and in patients with malabsorption
1973 · T. Shimoyama, H. Kikuchi, et al. · Gut · 37
PDF
Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
2022 · Katsuyoshi Matsuoka, Toshimitsu Fujii, et al. · Journal of Gastroenterology · 34
Impact of Preoperative Nutritional Status on the Incidence Rate of Surgical Complications in Patients With Inflammatory Bowel Disease With Vs Without Preoperative Biologic Therapy: A Case-Control Study
2019 · Takayuki Yamamoto, Takahiro Shimoyama, et al. · Clinical and Translational Gastroenterology · 33
Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn’s disease: a long-term prospective study
2016 · Takayuki Yamamoto, Takahiro Shimoyama, et al. · Therapeutic Advances in Gastroenterology · 27
A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis
2018 · Takayuki Yamamoto, Takayuki Iida, et al. · Clinical and Translational Gastroenterology · 26
Nutrition and diet in inflammatory bowel disease
2023 · Takayuki Yamamoto, Takahiro Shimoyama · Current Opinion in Gastroenterology · 24
Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases
2018 · Satoru Kondo, Toshimitsu Araki, et al. · Clinical Journal of Gastroenterology · 23
Coronary Microvascular Dysfunction Restored After Surgery in Inflammatory Bowel Disease: A Prospective Observational Study
2021 · Kentaro Kakuta, Kaoru Dohi, et al. · Journal of the American Heart Association · 18
PDF
Faecal biomarkers for screening small bowel inflammation in patients with Crohn’s disease: a prospective study
2017 · Takahiro Shimoyama, Takayuki Yamamoto, et al. · Therapeutic Advances in Gastroenterology · 16
PDF
Monitoring and detection of disease recurrence after resection for Crohn’s disease: the role of non-invasive fecal biomarkers
2017 · Takayuki Yamamoto, Takahiro Shimoyama · Expert Review of Gastroenterology & Hepatology · 14
Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study
2018 · Takahiro Shimoyama, Takayuki Yamamoto, et al. · BMC Gastroenterology · 10
PDF
Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study
2016 · Takayuki Yamamoto, Toshiaki Tanaka, et al. · Therapeutic Advances in Gastroenterology · 8
Kasai, Kobayashi and Koch's postulates in the history of Helicobacter pylori
2002 · Yuji Fukuda, T Shimoyama, et al. · 8
Works count: 94
Citation count: 1,131
H-index: 19
I10-index: 23
Year
Topic
Type